🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
CI
NYSE
🇺🇸 US
Cigna Corporation
Healthcare
32Score
DipBuster Score™
$283.94
+$2.49 (+0.88%)
Live price · Source: Yahoo
52-Week Position
$239.51
58% of range
$315.47
Beta
0.303
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.303
52W High$315.47
52W Low$239.51
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (58% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position58% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.303
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Cigna Corporation (CI), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-06-12 | Kates Jamie G | SELL | 899 |
| 2026-06-12 | Kates Jamie G | SELL | 899 |
| 2026-06-12 | Kates Jamie G | BUY | 899 |
| 2026-06-01 | Koka Durga Prasad | SELL | 729 |
| 2026-05-29 | Kurian George | BUY | 108 |
| 2026-05-13 | Cordani David | SELL | 7,971 |
| 2026-05-13 | Cordani David | SELL | 15,458 |
| 2026-05-13 | Cordani David | BUY | 7,971 |
| 2026-05-13 | Cordani David | BUY | 15,458 |
| 2026-05-12 | Cordani David | SELL | 85,519 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.303
Dividend/yrNone
52W High$315.47
52W Low$239.51
52-Week Range
$239.51Now$315.47
58% through annual range
From 52W High−10%
From 52W Low+18.6%
📖 Plain English Summary
Cigna Corporation is at 58% of its 52-week range. Beta 0.303 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for CI
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — CI
Heuristic · balance sheet, insider filings, price data, academic research
Cigna Corporation — DipBuster Score 32/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Cigna Corporation free
Add CI to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
17/25
Momentum & Volume
10/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
15
/100 · NEUTRAL
dip depth
15/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Insiders' avg buy price: $241.88 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 32/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth d…
Sector
Healthcare
Market
🇺🇸 US
CEO
Brian C. Evanko
Staff
67,700 employees
Website